ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Motivating Factors That Play a Role in Bulimia Nervosa

This study is currently recruiting participants.
Information provided by National Institute of Mental Health (NIMH)

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Motivating Factors That Play a Role in Bulimia Nervosa
Official Title  Translational Research on Eating Disorders: Behavioral Assessment of Motivation to Eat
Brief Summary

This study will evaluate whether people with bulimia nervosa will binge eat in a structured laboratory setting and display behavioral patterns similar to those of individuals who are dependent on drugs.

Detailed Description

Bulimia nervosa (BN) is a serious eating disorder that is characterized by frequent uncontrolled eating binges. These binges are often followed by compensatory behavior, including the following: self-induced vomiting; misuse of laxatives, diuretics, enemas, or other medications to induce purging; fasting; or excessive exercise. If left untreated, BN can lead to many serious health issues: tooth decay; irregular menstruation; bowel damage; constipation; heart and kidney disease; intestinal damage; puffiness, especially in the face and fingers; increased hair growth on the face and body; and mineral imbalances in the body. Similar to drug abuse disorders, food-related thinking and disordered eating behavior can interfere with other occupational and social activities, as well. This study will evaluate whether people with bulimia nervosa will binge eat in a structured laboratory setting and display behavioral patterns similar to those of individuals who are dependent on drugs.

Interested participants will first report to the study site for a screening visit, during which they will be assessed for eligibility using blood tests and an interview. Eligible participants will return to the study site on 3 additional days. Participants will be asked to refrain from eating or drinking between 10 P.M. each night before reporting to the study site and 10 A.M. the next day. Each day, participants will receive breakfast, after which they will not be allowed to eat or drink until the end of the day. Participants will then use a computer program to earn food (a yogurt shake) by tapping on the keyboard. More taps on the keyboard will result in a larger amount of food earned by the end of the day. Once experimentation is complete on Day 1, participants will be instructed to eat as much as they can. On Days 2 and 3, participants will be given a small serving of the yogurt shake prior to beginning the computer task. Following the computer task, they will be instructed to either eat until they are comfortable (without restricting or binging), or eat as much as they can. A private bathroom will be available if needed. All participants, including those who did not meet criteria for participation, will be offered treatment at the study clinic once the study is complete.

Study Phase
Study Type  Observational
Study Design  Case Control, Prospective
Primary Outcome Measure  Breakpoint [ Time Frame: Measured at Day 3 ] [ Designated as safety issue: No ]
Total work performed on progressive task [ Time Frame: Measured at Day 3 ] [ Designated as safety issue: No ]
Secondary Outcome Measure 
Condition  Bulimia Nervosa
Eating Disorders
Intervention  Behavioral: Motivation to eat
MEDLINE PMIDs
Links
Recruitment Information Fields
Recruitment Status  Recruiting
Enrollment  32
Start Date  May 2005
Completion Date February 2008
Eligibility Criteria 

Inclusion Criteria:

Participants with Bulimia Nervosa:

  • Meets DSM-IV criteria for bulimia nervosa
  • Duration of illness is greater than 1 year
  • Self-induces vomiting
  • Weighs between 80% and 120% of ideal weight

Control Group:

  • Weighs between 80% and 120% of ideal weight

Exclusion Criteria:

Participants with Bulimia Nervosa:

  • Significant medical illness
  • Current Axis I illness other than major depression
  • Severe or very severe depression
  • At risk for suicide
  • Currently taking medication
  • History of drug or alcohol abuse within the 6 months prior to study entry
  • Pregnant

Control Group:

  • Significant medical illness
  • Currently taking medication
  • History of drug or alcohol abuse within the 6 months prior to study entry
  • Pregnant
  • Current or history of psychiatric illness
  • History of any eating disorder
Gender Both
Ages 18 Years to 45 Years
Accepts Healthy Volunteers Yes
Contacts ††
Contact: Amanda J. Brown, BA     212-543-5151     edru@pi.cpmc.columbia.edu    
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00304174
Organization ID R21 MH65024-05
Secondary IDs †† DNBBS 72-NBR
Study Sponsor  National Institute of Mental Health (NIMH)
Collaborators ††
Investigators 
Principal Investigator:     B. T. Walsh, MD     New York State Psychiatric Institute at Columbia University Medical Center    
Information Provided By National Institute of Mental Health (NIMH)
Verification Date June 2008
First Received Date  March 15, 2006
Last Updated Date June 5, 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers